Are you Dr. Hodes?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Bldg. 31, Room 5c35, National Institutes Of Health
9000 Rockville Pike
Bethesda, MD 20892Phone+1 301-496-9265Fax+1 301-496-2525
Summary
- Dr. Richard Hodes, MD is an oncologist in Bethesda, Maryland. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1971 - 1973
Harvard Medical SchoolClass of 1971
Certifications & Licensure
MA State Medical License 1973 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1999
- Elected Member The American Society for Clinical Investigation, 1987
Publications & Presentations
PubMed
- ATM-deficient murine thymic T-cell lymphoblastic lymphomas are PTEN-deficient and require AKT signaling for survival.Joseph B An, Karen S Hathcock, Seth M Steinberg, Hyoyoung M Choo-Wosoba, Richard J Hodes
Plos One. 2024-01-01 - 2 citationsTRAF6 and TRAF2/3 Binding Motifs in CD40 Differentially Regulate B Cell Function in T-Dependent Antibody Responses and Dendritic Cell Function in Experimental Autoimmu...Ying Lu, Jeffrey Chiang, Ray Zhang, Paul A Roche, Richard J Hodes
Journal of Immunology. 2023-12-15 - 4 citationsCD40 Drives Central Nervous System Autoimmune Disease by Inducing Complementary Effector Programs via B Cells and Dendritic Cells.Ying Lu, Max Xu, Cayce E Dorrier, Ray Zhang, Christian T Mayer
Journal of Immunology. 2022-12-01
Press Mentions
Alzheimer’s Progression in down Syndrome Appears Similar to Other Genetic, Early Onset Forms of the DiseaseDecember 13th, 2022- Cell by Cell, Scientists Build High-Res Map of Alzheimer’s Brain ChangesJuly 28th, 2022
- Landmark Alzheimer's Prevention Trial Unable to Show Significantly Slower Cognitive Decline in Inherited Form of DiseaseJune 16th, 2022
- Join now to see all
Grant Support
- Regulation Of Lymphocyte Proliferation And Replicative CapacityNational Cancer Institute2010–2011
- Receptor Mediated T And B Cell ActivationNational Cancer Institute2010–2011
- Analysis Of The T Cell RepertoireNational Cancer Institute2010–2011
- Regulation Of Lymphocyte Proliferation And Replicative CapacityDivision Of Basic Sciences - Nci2009
- Receptor Mediated T And B Cell ActivationDivision Of Basic Sciences - Nci2009
- Analysis Of The T Cell RepertoireDivision Of Basic Sciences - Nci2009
- Regulation Of Lymphocyte Proliferation And Replicative CapacityNational Cancer Institute2007–2008
- Receptor Mediated T And B Cell ActivationNational Cancer Institute2007–2008
- Analysis Of The T Cell RepertoireNational Cancer Institute2007–2008
- Regulation Of Lymphocyte Proliferation And Replicative CDivision Of Basic Sciences - Nci2002–2006
- Receptor Mediated T And B Cell ActivationDivision Of Basic Sciences - Nci1996–2006
- Analysis Of The T Cell RepertoireDivision Of Basic Sciences - Nci1996–2006
- T Cell Regulation Of B Cell ActivationDivision Of Basic Sciences - Nci1997–2005
- Lymphocyte Proliferation And Replicative CapacityDivision Of Basic Sciences - Nci2004
- Regulation Of Lymphocyte Proliferation And ReplicationDivision Of Basic Sciences - Nci2003
- Regulation Of Lymphocyte ProliferationDivision Of Basic Sciences - Nci2001
- Regulation Of Lymphocyte Proliferation And Replicative CapacityDivision Of Basic Sciences - Nci1997–2000
- T Cell Regulation And B Cell ActivationDivision Of Basic Sciences - Nci1996
- Regulation Of Lymphocyte Proliferation And Cell Cycle ProgressionDivision Of Basic Sciences - Nci1996
